文献速递神经肿瘤功能神经外科

继发性肿瘤相关三叉神经痛伽玛刀放射外科治疗后影响长期疼痛控制的因素

Factors Affecting Long-Term Pain Control After Gamma Knife Radiosurgery in Secondary Tumor-Related Trigeminal Neuralgia.
PubMed 文献 · Neurosurgery · 2025-05-09

该回顾性研究分析156例继发性肿瘤相关三叉神经痛患者接受伽玛刀放射外科治疗后的疼痛结局,平均随访49.7±17.1个月,38.8%患者达到完全疼痛缓解(BNI 1),47.4%达到充分疼痛缓解(BNI 2-3)。多因素分析显示年龄<50岁(OR 6.95)和随访时肿瘤体积增大(OR 40.38)预测疼痛缓解失败;年龄≥50岁和肿瘤体积缩小或稳定显著预测BNI 1-3疼痛缓解。

要点

  • 伽玛刀治疗后继发性肿瘤相关三叉神经痛完全缓解率38.8%,充分缓解率47.4%。
  • 年龄<50岁(OR 6.95,95%CI 2-22.8,P=.001)预测疼痛缓解失败。
  • 随访时肿瘤体积增大(OR 40.38,95%CI 5.39-321.45,P<.001)预测疼痛缓解失败。

核心结论

  • 伽玛刀放射外科对继发性肿瘤相关三叉神经痛有效,38.8%患者完全疼痛缓解,47.4%患者充分疼痛缓解。
  • 年龄≥50岁和肿瘤体积缩小或稳定显著预测末次随访时BNI 1-3疼痛缓解。
  • 疼痛缓解与长期肿瘤控制相关,但并非唯一影响因素。

研究设计与样本

  • 回顾性分析本中心所有因继发性三叉神经痛接受伽玛刀放射外科治疗的患者,记录术前临床和影像学数据,评估随访时BNI疼痛评分和肿瘤体积。
  • 共纳入156例患者(90例女性,66例男性),平均年龄52.2±13.9岁,平均随访49.7±17.1个月,4例(2.5%)失访。
  • 分析预测疼痛缓解的因素,包括长期肿瘤控制。

主要发现

  • 最常见的病理为神经鞘瘤(108例,67.9%),其次为脑膜瘤(48例,29.6%)。
  • 伽玛刀平均剂量为12.08±5.5 Gy。
  • 末次随访时,59例(38.8%)达到完全疼痛缓解(BNI 1),72例(47.4%)达到充分疼痛缓解(BNI 2和3),21例(13.8%)疼痛缓解失败。
  • 多因素分析显示年龄<50岁(OR 6.95,95%CI 2-22.8,P=.001)和随访时肿瘤体积增大(OR 40.38,95%CI 5.39-321.45,P<.001)预测疼痛缓解失败。
  • 最常见的并发症为面部感觉减退,影响8.3%的患者。

关键数值与推荐

  • 完全疼痛缓解定义为BNI 1,充分疼痛缓解定义为BNI 2和3,疼痛缓解失败定义为BNI 4和5。
  • 年龄<50岁预测疼痛缓解失败的OR为6.95(95%CI 2-22.8,P=.001)。
  • 随访时肿瘤体积增大预测疼痛缓解失败的OR为40.38(95%CI 5.39-321.45,P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Trigeminal neuralgia (TN) can often result from compression of the trigeminal root by various tumors. Although the efficacy of Gamma Knife radiosurgery (GKRS) in treating these tumors is well documented, it remains to be determined if tumor control drives pain relief in tumor-related TN. METHODS: We retrospectively analyzed all patients who underwent GKRS for secondary TN at our center, recording preoperative clinical and radiological data, and assessing outcomes regarding Barrow Neurological Institute (BNI) pain scores and tumor volume at follow-up. We then analyzed the factors that predicted pain relief, including long-term tumor control. RESULTS: The mean age of 156 patients (90 women and 66 men) was 52.2 ± 13.9 years. The most frequent pathology was schwannoma (108 cases, 67.9%), followed by meningioma (48 cases, 29.6%). The mean dose of GKRS administered was 12.08 ± 5.5 Gy. The mean follow-up was 49.7 ± 17.1 months. Four patients (2.5%) were lost to follow-up. At latest follow-up, 59 patients (38.8%) achieved complete pain relief (BNI 1), whereas 72 patients (47.4%) achieved adequate pain relief (BNI 2 and 3). Failure of pain relief occurred in 21 patients (13.8%). Multivariate analysis revealed that patients aged younger than 50 years (odds ratio: 6.95, 95% CI: 2, 22.8, P = .001) and increase in tumor volume at follow-up (odds ratio: 40.38, 95% CI: 5.39, 321.45, P < .001) predicted failure of pain relief. CONCLUSION: GKRS is effective among patients with secondary tumor-related TN, with complete pain relief in 38.8% of patients and adequate pain relief in 47.4%. The most frequent complication is facial hypesthesia, affecting 8.3% of patients. Age ≥50 years and decreased or stable tumor volume significantly predict BNI 1-3 pain relief at the latest follow-up. Although pain relief is linked to long-term tumor control, it is not the sole factor at play.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Goyal-Honavar A, Kumar A C, Dwarakanath S, et al. Factors Affecting Long-Term Pain Control After Gamma Knife Radiosurgery in Secondary Tumor-Related Trigeminal Neuralgia. Neurosurgery. 2025. PMID: 40341571. doi:10.1227/neu.0000000000003503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。